Abstract
The cationic vesicle composed of Span80 and cationic peptide lipid (CPL) was prepared. The cytotoxicity of the Span80-CPL cationic vesicle was very low compared with Span80 vesicle. Antibody was able to be immobilized on vesicle surface by mediation of protein A. The antigen targeting ability of the antibody-immobilized vesicle (immunovesicle) derived from antibody was evaluated. Our results suggested that the Span80-CPL immunovesicles specifically associate with target cells by the antibody mediation, and the substance capsulated in immunovesicle was transferred into the target cells. This means that the Span80-CPL immunovesicle is expected to achieve a high local concentration of an encapsulated drug at the target.
Similar content being viewed by others
Abbreviations
- CPL:
-
cationic peptide lipid
- FBS:
-
fetal bovine serum
- FITC:
-
fluorescein isothiocyanate
- IADE:
-
isothiocyanic acid dodecyl ester
- PBS:
-
phosphate buffered saline
- PI:
-
propidium iodide
- Span80:
-
sorbitan monooleate
- Tween80:
-
polyoxyethylene (20) sorbitan monooleate
References
G. Bendas (2001) ArticleTitleImmunoliposomes: a promising approach to targeting cancer therapy BioDrugs 15 215–224 Occurrence Handle11437687 Occurrence Handle1:CAS:528:DC%2BD3MXkvVOjtrY%3D
K. Kato T. Sugahara S. Kawashima Y. Hayashi A. Yoshihiro T. Sasaki (1999) Study of the specific binding between lipid vesicles and human–human hybridoma toward either DDS or gene transfection A. Bernard (Eds) et al. Animal Cell Technology: Products from Cells, Cells as Products Kluwer Academic Publishers The Netherlands 433–435
K. Kato T. Ikeda M. Shinozaki (1993) ArticleTitleLipid-membrane characteristics of large lipid-vesicles prepared by two-step emulsification technique and enzymatic NAD+-recycling in the vesicle J. Chem. Eng. Japan 26 212–216 Occurrence Handle10.1252/jcej.26.212 Occurrence Handle1:CAS:528:DyaK3sXisFWjsb0%3D
S. Kessner A. Krause U. Rothe G. Bendas (2001) ArticleTitleInvestigation of the cellular uptake of E-Selectin-treated immunoliposomes by activated human endothelial cells Biochim. Biophys. Acta 1541 177–190
K. Maruyama N. Takahashi T. Tagawa K. Nagaike M. Iwatsuru (1997) ArticleTitleImmunoliposomes bearing polyethyleneglycol-coupled Fab’ fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo FEBS Lett. 413 177–180 Occurrence Handle10.1016/S0014-5793(97)00905-8 Occurrence Handle9287139 Occurrence Handle1:CAS:528:DyaK2sXlt1Glt78%3D
H. Murakami H. Masui G.H. Sato N. Sueoka T.P. Chow T. Kono-Sueoka (1982) ArticleTitleGrowth of hybridoma cells in serum-free medium Proc. Natl. Acad. Sci. USA 79 1158–1162 Occurrence Handle7041116 Occurrence Handle1:CAS:528:DyaL38Xht1SmtrY%3D
H. Murakami S. Hashizume H. Ohashi K. Shinohara K. Yasumoto K. Nomoto H. Omura (1985) ArticleTitleHuman–human hybridomas secreting antibodies specific to human lung carcinoma In Vitro Cell. Dev. Biol. 21 593–596 Occurrence Handle3902783 Occurrence Handle1:STN:280:BimD3szkvFc%3D
Y. Murakami A. Naklano H. Ikeda (1982) ArticleTitlePreparation of stable single-compartment vesicles with cationic and zwitterionic amphiphiles involving amino acid residues J. Org. Chem. 47 2137–2144 Occurrence Handle10.1021/jo00132a030 Occurrence Handle1:CAS:528:DyaL38XitVSisbo%3D
Y. Murakami A. Nakano A. Yoshimatsu K. Uchitomi Y. Matsuda (1984a) ArticleTitleCharacterization of molecular aggregates of peptide amphiphiles and kinetics of dynamic processes performed by single-walled vesicle J. Am. Chem. Soc. 106 3613–3623 Occurrence Handle10.1021/ja00324a034 Occurrence Handle1:CAS:528:DyaL2cXktValtr4%3D
Y. Murakami Y. Hisaeda T. Ohno (1984b) ArticleTitleHydrophobic vitamin B12. III. Incorporation of hydrophobic vitamin B12 derivatives into single-compartment vesicles and their alkylation in various molecular aggregates Bull. Chem. Soc. Jpn. 57 2091–2097 Occurrence Handle1:CAS:528:DyaL2MXls1Sr
Y. Murakami Y. Hisaeda T. Ohno (1991) ArticleTitleHydrophobic vitamin B12. Part 9. An artificial holoenzyme composed of hydrophobic vitamin B12 and synthetic bilayer membrane for carbon-skeleton rearrangements J. Chem. Soc. Perkin Trans. 2 405–416
J.W. Park K. Hong D.B. Kirpotin G. Colbern R. Shalaby J. Baselga Y. Shao U.B. Nielsen J.D. Marks D. Moore D. Papahadjopoulos C.C. Benz (2002) ArticleTitleAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery Clin. Cancer Res. 8 1172–1181 Occurrence Handle11948130 Occurrence Handle1:CAS:528:DC%2BD38XjsF2lt7g%3D
T. Sugahara Y. Ohama A. Fukuda M. Hayashi A. Kawakubo K. Kato (2001) ArticleTitleThe cytotoxic effect of Eucheuma serra agglutinin (ESA) on cancer cells and its application to molecular probe for drug delivery system using lipid vesicles Cytotechnology 36 93–99 Occurrence Handle10.1023/A:1014057407251 Occurrence Handle1:CAS:528:DC%2BD38XovV2ktA%3D%3D
T. Yoshioka B. Sternberg A.T. Florence (1994) ArticleTitlePreparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span85) Int. J. Pharm. 105 1–6 Occurrence Handle10.1016/0378-5173(94)90228-3 Occurrence Handle1:CAS:528:DyaK2cXjtVOgsb8%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sugahara, T., Kawashima, S., Oda, A. et al. Preparation of Cationic Immunovesicles Containing Cationic Peptide Lipid for Specific Drug Delivery to Target Cells. Cytotechnology 47, 51–57 (2005). https://doi.org/10.1007/s10616-005-3764-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10616-005-3764-5